Abstract
Background:
Accurate reference intervals (RIs) based on a healthy pediatric population are essential for pediatric test result interpretation. The CALIPER project has recruited a large healthy cohort and completed a series of a priori studies to address gaps in pediatric RIs. As immunoassays from different manufacturers for endocrine and special chemistry markers are not standardized and show marked intermethod differences, direct RI studies are needed for each major analytical platform. Here, we report age- and sex-specific pediatric RIs for 29 immunoassays on the Ortho Clinical Diagnostics (Ortho) VITROS® 5600 analyzer.
Methods:
Health information and blood samples were collected from healthy pediatric subjects. Using the Ortho VITROS 5600 Integrated System MicroWell Technology, 29 biomarkers were measured. Analyte concentrations were partitioned by age and sex according to the Harris and Boyd method. After removing outliers, age- and sex-specific RIs and corresponding 90% confidence intervals were calculated according to CLSI guidelines.
Results:
All analytes required age partitioning except β-human chorionic gonadotropin (β-hCG), cancer antigen 15-3 (CA15-3), rubella immunoglobulin G (rubella IgG), and vitamin D. Several analytes including estradiol, progesterone, testosterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), free triiodothyronine (FT3), total triiodothyronine (TT3), total thyroxine (TT4), thyroid uptake, ferritin, intact parathyroid hormone (iPTH), total prostate-specific antigen (tPSA), free prostate-specific antigen (fPSA), cancer antigen 125 (CA125), creatine kinase MB (CK-MB), and myoglobin showed sex differences, observed mostly with the onset of puberty.
Conclusions:
Complex reference value trends were observed across the pediatric age range for several biomarkers examined on Ortho VITROS immunoassays. The availability of VITROS immunoassay RIs will enable accurate laboratory test interpretation and diagnosis for the pediatric population. As recommended by the CLSI EP28-A3c guidelines, implementation of these RIs should be validated for each laboratory’s local pediatric population.
Acknowledgments
We thank all the participants and their families for their participation. We would also like to thank Dr. Maria Patru from Ortho Clinical Diagnostics (OCD) for critical review of the manuscript.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This study was supported by operating grants from the Canadian Institutes of Health Research (CIHR) (grant/award number: 353989) as well as a study grant from OCD to KA. The Ortho VITROS 5600 reagents used in the study were provided by OCD.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Jung B, Adeli K. Clinical laboratory reference intervals in pediatrics: the CALIPER initiative. Clin Biochem 2009;42:1589–95.10.1016/j.clinbiochem.2009.06.025Search in Google Scholar
2. Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 2012;58:854–68.10.1373/clinchem.2011.177741Search in Google Scholar
3. Bailey D, Colantonio D, Kyriakopoulou L, Cohen AH, Chan MK, Armbruster D, et al. Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem 2013;59:1393–405.10.1373/clinchem.2013.204222Search in Google Scholar
4. Konforte D, Shea JL, Kyriakopoulou L, Colantonio D, Cohen AH, Shaw J, et al. Complex biological pattern of fertility hormones in children and adolescents: a study of healthy children from the CALIPER cohort and establishment of pediatric reference intervals. Clin Chem 2013;59:1215–27.10.1373/clinchem.2013.204123Search in Google Scholar
5. Bevilacqua V, Chan MK, Chen Y, Armbruster D, Schodin B, Adeli K. Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort. Clin Chem 2014;60:1532–42.10.1373/clinchem.2014.229799Search in Google Scholar
6. Raizman JE, Cohen AH, Teodoro-Morrison T, Wan B, Khun-Chen M, Wilkenson C, et al. Pediatric reference value distributions for vitamins A and E in the CALIPER cohort and establishment of age-stratified reference intervals. Clin Biochem 2014;47:812–5.10.1016/j.clinbiochem.2014.03.025Search in Google Scholar
7. Teodoro-Morrison T, Kyriakopoulou L, Chen YK, Raizman JE, Bevilacqua V, Chan MK, et al. Dynamic biological changes in metabolic disease biomarkers in childhood and adolescence: a CALIPER study of healthy community children. Clin Biochem 2015;48:828–36.10.1016/j.clinbiochem.2015.05.005Search in Google Scholar
8. Raizman JE, Quinn F, Armbruster DA, Adeli K. Pediatric reference intervals for calculated free testosterone, bioavailable testosterone and free androgen index in the CALIPER cohort. Clin Chem Lab Med 2015;53:e239–43.10.1515/cclm-2015-0027Search in Google Scholar
9. Kelly J, Raizman JE, Bevilacqua V, Chan MK, Chen Y, Quinn F, et al. Complex reference value distributions and partitioned reference intervals across the pediatric age range for 14 specialized biochemical markers in the CALIPER cohort of healthy community children and adolescents. Clin Chim Acta Int J Clin Chem 2015;450:196–202.10.1016/j.cca.2015.08.020Search in Google Scholar
10. Estey MP, Cohen AH, Colantonio DA, Chan MK, Marvasti TB, Randell E, et al. CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens clinical chemistry assays: direct validation using reference samples from the CALIPER cohort. Clin Biochem 2013;46:1197–219.10.1016/j.clinbiochem.2013.04.001Search in Google Scholar
11. Higgins V, Chan MK, Nieuwesteeg M, Hoffman BR, Bromberg IL, Gornall D, et al. Transference of CALIPER pediatric reference intervals to biochemical assays on the Roche cobas 6000 and the Roche Modular P. Clin Biochem 2016;49:139–49.10.1016/j.clinbiochem.2015.08.018Search in Google Scholar
12. Abou El Hassan M, Stoianov A, Araújo PAT, Sadeghieh T, Chan MK, Chen Y, et al. CLSI-based transference of CALIPER pediatric reference intervals to Beckman Coulter AU biochemical assays. Clin Biochem 2015;48:1151–9.10.1016/j.clinbiochem.2015.05.002Search in Google Scholar
13. Araújo PAT, Thomas D, Sadeghieh T, Bevilacqua V, Chan MK, Chen Y, et al. CLSI-based transference of the CALIPER database of pediatric reference intervals to Beckman Coulter DxC biochemical assays. Clin Biochem 2015;48:870–80.10.1016/j.clinbiochem.2015.06.002Search in Google Scholar
14. Stenman UH. Immunoassay standardization: is it possible, who is responsible, who is capable? Clin Chem 2001;47:815–20.10.1093/clinchem/47.5.815Search in Google Scholar
15. Karbasy K, Lin DCC, Stoianov A, Chan MK, Bevilacqua V, Chen Y, et al. Pediatric reference value distributions and covariate-stratified reference intervals for 29 endocrine and special chemistry biomarkers on the Beckman Coulter Immunoassay Systems: a CALIPER study of healthy community children. Clin Chem Lab Med 2016;54:643–57.10.1515/cclm-2015-0558Search in Google Scholar
16. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guidelines – third edition CLSI document C28-A3. Clinical and Laboratory Standards Institute (CLSI), 2008.Search in Google Scholar
17. Tukey J. Exploratory data analysis. Boston: Addison-Wesley, 1977.Search in Google Scholar
18. Hubert M, Van der Veeken S. Outlier detection for skewed data. J Chemom 2008;22:235–46.10.1002/cem.1123Search in Google Scholar
19. Harris EK, Boyd JC. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990;36: 265–70.10.1093/clinchem/36.2.265Search in Google Scholar
20. Horn P, Pesce A. Reference Intervals: a user’s guide. Washington, DC: AACC Press, 2005.Search in Google Scholar
21. Bergadá I, Milani C, Bedecarrás P, Andreone L, Ropelato MG, Gottlieb S, et al. Time course of the serum gonadotropin surge, inhibins, and anti-Müllerian hormone in normal newborn males during the first month of life. J Clin Endocrinol Metab 2006;91:4092–8.10.1210/jc.2006-1079Search in Google Scholar
22. Garagorri JM, Rodríguez G, Lario-Elboj AJ, Olivares JL, Lario-Muñoz A, Orden I. Reference levels for 17-hydroxyprogesterone, 11-desoxycortisol, cortisol, testosterone, dehydroepiandrosterone sulfate and androstenedione in infants from birth to six months of age. Eur J Pediatr 2008;167:647–53.10.1007/s00431-007-0565-1Search in Google Scholar
23. Kuijper EA, Ket JCF, Caanen MR, Lambalk CB. Reproductive hormone concentrations in pregnancy and neonates: a systematic review. Reprod Biomed Online 2013;27:33–63.10.1016/j.rbmo.2013.03.009Search in Google Scholar
24. Kerlan V, Nahoul K, Le Martelot MT, Bercovici JP. Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy. Clin Endocrinol (Oxf) 1994;40:263–7.10.1111/j.1365-2265.1994.tb02478.xSearch in Google Scholar
25. Hohlagschwandtner M, Husslein P, Klier C, Ulm B. Correlation between serum testosterone levels and peripartal mood states. Acta Obstet Gynecol Scand 2001;80:326–30.10.1034/j.1600-0412.2001.080004326.xSearch in Google Scholar
26. Schubring C, Englaro P, Siebler T, Blum WF, Demirakca T, Kratzsch J, et al. Longitudinal analysis of maternal serum leptin levels during pregnancy, at birth and up to six weeks after birth: relation to body mass index, skinfolds, sex steroids and umbilical cord blood leptin levels. Horm Res 1998;50:276–83.10.1159/000023290Search in Google Scholar
27. Fisher DA. The unique endocrine milieu of the fetus. J Clin Invest 1986;78:603–11.10.1172/JCI112616Search in Google Scholar
28. Petraglia F, Angioni S, Coukos G, Uccelli E, DiDomenica P, De Ramundo BM, et al. Neuroendocrine mechanisms regulating placental hormone production. Contrib Gynecol Obstet 1991;18:147–56.10.1159/000418462Search in Google Scholar
29. Burtis CA, Ashwood E, Bruns D. Chapter 55: The thyroid: pathophysiology and thyroid function testing. In: Tietz textbook of clinical chemistry and molecular diagnostics, 5th ed. St. Louis, MO: Elsevier, 2012:1905–44.Search in Google Scholar
30. Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. American thyroid association guidelines for use of laboratory tests in thyroid disorders. JAMA 1990;263:1529–32.10.1001/jama.1990.03440110095035Search in Google Scholar
31. Soldin OP, Goughenour BE, Gilbert SZ, Landy HJ, Soldin SJ. Thyroid hormone levels associated with active and passive cigarette smoking. Thyroid Off J Am Thyroid Assoc 2009;19:817–23.10.1089/thy.2009.0023Search in Google Scholar
32. Cook JD, Skikne BS. Iron deficiency: definition and diagnosis. J Intern Med 1989;226:349–55.10.1111/j.1365-2796.1989.tb01408.xSearch in Google Scholar
33. Samuelson G, Lönnerdal B, Kempe B, Elverby JE, Bratteby LE. A follow-up study of serum ferritin and transferrin receptor concentrations in Swedish adolescents at age 17 years compared to age 15. Acta Paediatr 2000;89:1162–8.10.1111/j.1651-2227.2000.tb00729.xSearch in Google Scholar
34. Christenson RH, Azzazy HM. Biochemical markers of the acute coronary syndromes. Clin Chem 1998;44:1855–64.10.1093/clinchem/44.8.1855Search in Google Scholar
35. Bhayana V, Cohoe S, Pellar TG, Jablonsky G, Henderson AR. Combination (multiple) testing for myocardial infarction using myoglobin, creatine kinase-2 (mass), and troponin T. Clin Biochem 1994;27:395–406.10.1016/0009-9120(94)90044-2Search in Google Scholar
36. Dimech W, Grangeot-Keros L, Vauloup-Fellous C. Standardization of assays that detect anti-rubella virus IgG antibodies. Clin Microbiol Rev 2016;29:163–74.10.1128/CMR.00045-15Search in Google Scholar
Supplemental Material:
The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2017-0349).
©2018 Walter de Gruyter GmbH, Berlin/Boston